Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage

IntroductionImmunoglobulin replacement therapy (IgRT), either intravenous (IVIg) or subcutaneous (SCIg), is crucial for managing primary immune deficiencies (PIDs) with hypogammaglobulinemia by reducing infection rates and mortality. During the COVID-19 pandemic, a global shortage of SCIg prompted o...

Descrición completa

Detalles Bibliográficos

Principais autores:	Pedro Moral Moral, Marta Dafne Cabanero-Navalon, Paula Teresa López-León, Héctor Balastegui-Martín, Sandra Martínez Mercader, Amparo Mir, Victor Garcia-Bustos
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Assuntos:	immunoglobulin replacement therapy humoral primary immune deficiencies subcutaneous immunoglobulin infections cost-effectiveness resource shortage
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1527514/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!